Impact of targeted tuberculosis vaccination among a mining population in South Africa: A model based studyFriday, August 9, 2024Availability, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and IndiaFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Formative work to understand factors affecting future TB vaccines acceptanceFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Health system readiness, Health system readinessRead More
